Morphological alterations and the effect on tumour supressor gene expression induced by high dose rate intraluminal brachytherapy in oesophageal carcinoma

Morphological alterations and the effect on tumour supressor gene expression induced by high dose rate intraluminal brachytherapy in oesophageal carcinoma

1. To review the radiation changes in total oesophagectomy specimens from 10 patients with Squamous cell carcinoma [SCC], given preoperative High Dose Rate Intraluminal Brachytherapy [HDRILBT] of 20 Gy in two fractions of 10 Gy each weekly. 2. To evaluate the effect of HDR ILBT on p-glycoprotein...

Full description

Bibliographic Details
Main Author:	Sur, Monalisa
Format:	Others
Language:	en
Published:	2014
Online Access:	http://hdl.handle.net10539/14479

Similar Items

Long-term results of curative intraluminal high dose rate brachytherapy for endobronchial carcinoma
by: Kawamura Hidemasa, et al.
Published: (2012-07-01)

The role of brachytherapy alone and in conjunction with teletherapy or chemotherapy in advanced oesophageal carcinoma
by: Sur, Ranjan K
Published: (2014)

A method for verification of treatment times for high-dose-rate intraluminal brachytherapy treatment
by: Muhammad Asghar Gadhi, et al.
Published: (2016-06-01)

Oesophageal perforation during neo-adjuvant brachytherapy for oesophageal squamous cell carcinoma
by: Maryam H. Esfehani, et al.
Published: (2015-03-01)

High-dose-rate intraluminal brachytherapy prior to external radiochemotherapy in locally advanced esophageal cancer: preliminary results
by: Afsaneh Maddah Safaei, et al.
Published: (2017-01-01)

High dose rate intraluminal brachytherapy in the treatment of malignant airway obstructions in elderly patients: Preliminary results of single institution experience
by: Isaković-Vidović Suzana, et al.
Published: (2002-01-01)

Dose Intensified Chemoradiation and Intraluminal Brachytherapy Improve Outcomes in Middle Third Carcinoma Esophagus: Experience from a Regional Cancer Center
by: Tanvirpasha C. R., et al.
Published: (2020-03-01)

Loss of heterozygosity at 9q22-31 and examination of the PTCH tumour supressor gene in ovarian tumours
by: Byrom, Jennifer
Published: (2003)

Oesophageal squamous cell carcinoma mimicking submucosal tumour
by: Wen Wang, et al.
Published: (2021-04-01)

Endocrinology, oncogene and tumour suppressor gene expression in Barrett's oesophagus, oesophageal and gastric cardia carcinoma
by: Ritchie, Andrew John
Published: (1993)

Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma
by: Andrea Vavassori, et al.
Published: (2019-10-01)

Preoperative high dose rate brachytherapy for clinical stage II endometrial carcinoma
by: Alexander Olawaiye, et al.
Published: (2011-07-01)

Intraorbital pulse dose rate brachytherapy for myoepithelial carcinoma ex pleomorphic adenoma
by: Anup Narendra Chandak, et al.
Published: (2017-01-01)

Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy – a meta-analysis of clinical trials
by: Stefano Eduardo J, et al.
Published: (2009-04-01)

Pulsed dose rate brachytherapy – is it the right way?
by: Janusz Skowronek
Published: (2010-10-01)

Altered protein expression patterns in oesophageal cancer
by: Zemanay, Widaad
Published: (2014)

Pulsed Dose Rate Brachytherapy of Lip Carcinoma: Clinical Outcome and Quality of Life Analysis
by: Radouane El Ayachy, et al.
Published: (2021-03-01)

Case of oesophageal gastrointestinal stromal tumour
by: Barbara Łochowska, et al.
Published: (2017-12-01)

Impact of different dose prescription schedules on EQD2 in high-dose-rate intracavitary brachytherapy of carcinoma cervix
by: Mohan Kumar, et al.
Published: (2019-04-01)

HIGH DOSE-RATE BRACHYTHERAPY IN THE TREATMENT OF CERVICAL CANCER
by: M. V. Kiseleva, et al.
Published: (2018-08-01)

The Preliminary Prototype of Medium Dose Rate Brachytherapy Equipment
by: A. Satmoko, et al.
Published: (2013-08-01)

Small cell carcinoma of the prostate after low-dose-rate brachytherapy: a case report
by: Eva Van Bos, et al.
Published: (2020-10-01)

Medium dose rate brachytherapy for patients with cervical carcinoma; early result of a prospective study
by: Amouzegar Hashemi F, et al.
Published: (2009-03-01)

Combined interstitial and surface high-dose-rate brachytherapy treatment of squamous cell carcinoma of the hand
by: Daniel Kim, et al.
Published: (2020-01-01)

Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrence
by: Helen Pasternack, et al.
Published: (2018-10-01)

Family and tumour studies in breast and oesophageal cancer
by: Kelsell, David Peter
Published: (1996)

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
by: Lara Hathout, MD, FRCPC, et al.
Published: (2019-10-01)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
by: Hideya Yamazaki, et al.
Published: (2020-09-01)

Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
by: Justin Barnes, et al.
Published: (2019-07-01)

Biological effective doses in the intracavitary high dose rate brachytherapy of cervical cancer
by: Y. Sobita Devi, et al.
Published: (2011-12-01)

Dose distribution of Ir-192 high-dose-rate brachytherapy of prostate cancer
by: Tien-Chi Yeh, et al.
Published: (2006)

Image-guided interstitial high-dose-rate brachytherapy in the treatment of metastatic esophageal squamous cell carcinoma
by: Jazan Omari, et al.
Published: (2018-10-01)

High‐dose‐rate interstitial brachytherapy for a bulky sebaceous carcinoma of the eyelid: A case report
by: Yoshiaki Takagawa, et al.
Published: (2019-10-01)

High-dose-rate surface brachytherapy as a treatment option for renal cell carcinoma cutaneous metastases
by: Łukasz Raszewski, et al.
Published: (2021-05-01)

Multi-criteria optimization algorithms for high dose rate brachytherapy
by: Cui, Songye, et al.
Published: (2019)

High-dose rate brachytherapy in the treatment of cancer of the cervix uteri
by: D. A. Aliyev, et al.
Published: (2014-07-01)

Salvage high-dose-rate brachytherapy for recurrent prostate cancer
by: A. D. Kaprin, et al.
Published: (2021-02-01)

The oncologic outcomes of low-dose-rate brachytherapy for prostate cancer
by: N. Tanaka, et al.
Published: (2020-07-01)

High-dose-rate brachytherapy in the treatment of skin Kaposi sarcoma
by: María Ángeles González Ruiz, et al.
Published: (2017-12-01)

Focal low-dose rate brachytherapy for the treatment of prostate cancer
by: Tong WY, et al.
Published: (2013-09-01)

Cannot write session to /tmp/vufind_sessions/sess_026eipgdqfk8cbpk0c2jb4qa3c